Featured
Want to learn more about Pharmacovigilance and Risk Management Strategies Conference? You've come to the right site!
项目委员会
-
Stephen Knowles, MD, MRCP Chief Medical Officer
Halozyme Therapeutics, United States -
Lesley Wise, PHD, MSC Managing Director
Wise Pharmacovigilance and Risk Management, Ltd, United Kingdom -
Mariette Boerstoel-Streefland, MD, MBA, MS Senior Vice President, Patient Safety Officer
Bristol Myers Squibb, United States -
Cheryl Campbell, MS Associate Director of Executive Operations/Outreach and Communications, OSE,CDER
FDA, United States -
E. Stewart Geary, MD MD, Global Safety Officer
Eisai Co., Ltd., Japan -
Lisa Melanie Harinstein, PHARMD Team Leader, Division of Pharmacovigilance, FDA
FDA, United States -
Jeremy Jokinen, PHD, MS Vice President and Head Global Patient Safety
Argenx, United States -
Annette Stemhagen, DrPH, PHD, FISPE Chief Science Officer
UBC, United States -
Sarah Vaughan Head of Vigilance Operations
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom -
Annette S. Williams, MBA, RPH Vice President, Pharmacovigilance
IQVIA, United States -
Jo Wyeth, PHARMD Associate Director for Postmarket Assessments, OMEPRM, OSE, CDER
FDA, United States -
Stella Blackburn, MD, MA, MSC, FFPM, FISPE, FRCP Strategy
Consultant, United Kingdom -
William Gregory, PHD Senior Director, Safety and Risk Management
Pfizer Inc, United States -
Valerie E. Simmons, MD, FFPM Senior Medical Fellow, Global Patient Safety
Eli Lilly and Company Ltd, United Kingdom
